As of Thursday close, Ardelyx Inc.’s (NASDAQ:ARDX) stock was down -$0.21, moving down -5.65 percent to $3.51. The average number of shares traded per day over the past five days has been 3,589,860 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.53 fall in that time frame. In the last twenty days, the average volume was 4,090,700, while in the previous 50 days, it was 4,756,922.
Since last month, ARDX stock rose 0.86%. Shares of the company fell to $3.39 on 07/20/23, the lowest level in the past month. A 52-week high of $5.12 was reached on 04/17/23 after having rallying from a 52-week low of $0.82. Since the beginning of this year, ARDX’s stock price has risen by 23.16% or $0.66, and marked a new high 16 times. However, the stock has declined by -31.51% since its 52-week high.
ARDX stock investors should be aware that Ardelyx Inc. (ARDX) stock had its last reported insider trading activity 52 days ago on Jun 27. Williams Laura A, the Chief Medical Officer of the company, disposed of 25,000 shares for $3.35 on Jun 27. It resulted in a $83,632 divestment by the insider. Blanks Robert sold 33,333 shares at an average price of $3.63 on Jun 23. The insider now owns 266,134 shares following the transaction. On May 23, President & CEO RAAB MICHAEL sold 11,357 shares at $3.65 apiece. The transaction was valued at $41,489.
Valuation Metrics
The stock’s beta is 1.18. Besides these, the trailing price-to-sales (P/S) ratio of 9.29, the price-to-book (PB) ratio of 6.16.
Financial Health
In the three months ended June 29, Ardelyx Inc.’s quick ratio stood at 2.50, while its current ratio was 2.60, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 89.20% percent. In the year ended June 29, EBITDA margin amounted to -113.42%, whereas operating margins totaled -63.20%. Based on annual data, ARDX earned $48.04 million in gross profit and brought in $52.16 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -51.00%. Return on equity (ROE) for the past 12 months was -54.20%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ARDX’s revenue rose 95.87% to $44.18 million during the quarter, while net income inched up to $11.37 million. While analysts expected Ardelyx Inc. to report -$0.11 quarterly earnings, the actual figure was -$0.08 per share, beating the consensus estimate by 27.30%. During the quarter, the company generated -$15.98 million in EBITDA. The liabilities of Ardelyx Inc. were 88.04 million at the end of its most recent quarter ended June 29, and its total debt was $34.91 million. The value of shareholders’ equity is $217.86 million.
Technical Picture
This quick technical analysis looks at Ardelyx Inc.’s (ARDX) price momentum. With a historical volatility rate of 46.55%, the RSI 9-day stood at 33.65% on 17 August.
With respect to its five-day moving average, the current Ardelyx Inc. price is down by -13.12% percent or -$0.53. At present, ARDX shares trade +2.63% above its 20-day simple moving average and -12.25% percent below its 100-day simple moving average. However, the stock is currently trading approximately -5.90% below its SMA50 and +154.35% above its SMA200.
Stochastic coefficient K was 20.99% and Stochastic coefficient D was 42.63%, while ATR was 0.19. Given the Stochastic reading of 2.07% for the 14-day period, the RSI (14) reading has been calculated as 40.63%. As of today, the MACD Oscillator reading stands at -0.16, while the 14-day reading stands at -0.19.
Analyst Ratings
Wedbush upgraded its rating on Ardelyx Inc. (NASDAQ: ARDX) to an Outperform in a note to investors on March 03, 2023. The analysts firm previously had a Neutral rating on the stock.Ardelyx Inc. (ARDX) has been rated Buy by analysts. According to 0 brokerage firms, ARDX is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Ardelyx Inc. stock as buy, with 6 recommending it as overweight.
With a median target price of $7.00, the current consensus forecast for the stock is $5.00 – $12.00. Based on these forecasts, analysts predict Ardelyx Inc. (ARDX) will achieve an average price target of $7.58.
